Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT00235820 · COMPLETED
Trial details
- NCT number
- NCT00235820
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2006-05-01
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.